RSS-Feed abonnieren
DOI: 10.1055/s-2003-40335
An Efficient Route to Pyrimidine Nucleosides with the 2,3-Anhydro-β-d-lyxofuranosyl Stereochemistry
Publikationsverlauf
Publikationsdatum:
30. Juni 2003 (online)
Abstract
Described is the efficient preparation of 2,3-anhydro-β-d-lyxofuranosyl pyrimidine nucleosides via the coupling of a 2,3-anhydrosugar-containing glycosyl donor (5 or 6) with a silylated nucleoside base. The products are obtained with a high degree of stereoselectivity and in 65-77% yield.
Key words
epoxides - glycosylations - carbohydrates - nucleosides - anhydrosugars
- See, for example:
-
1a
Huryn DM.Okabe M. Chem. Rev. 1992, 92: 1745 -
1b
Chen YCJ.Hansske F.Janda KD.Robins MJ. J. Org. Chem. 1991, 56: 3410 -
1c
Roussev CD.Simeonov MF.Petkov DD. J. Org. Chem. 1997, 62: 5238 -
1d
Miah A.Reese CB.Song Q.Sturdy Z.Neidle S.Simpson IJ.Read M.Rayner E. J. Chem. Soc., Perkin Trans. 1 1998, 3277 -
1e
Hirota K.Takasu H.Sajiki H. Heterocycles 2000, 52: 1329 - For representative examples:
-
2a
Codington JF.Fecher R.Fox JJ. J. Org. Chem. 1962, 27: 163 -
2b
Williams NR. Adv. Carbohydr. Chem. Biochem. 1970, 25: 109 -
2c
Hollenberg DH.Watanabe KA.Fox JJ. J. Med. Chem. 1977, 20: 113 -
3a
Dimoglo AS.Gorbachov MY.Lesnik TI.Saracoglu M.Güzel Y.Yildirim I. Curr. Med. Chem. 1997, 4: 23 -
3b
Webb TR.Mitsuya H.Broder S. J. Med. Chem. 1988, 31: 1475 - For additional examples see:
-
4a
Chang NC.Burchanel R.Fecher R.Duschinsky R.Fox JJ. J. Am. Chem. Soc. 1961, 83: 4060 -
4b
Shiragami H.Tanaka Y.Uchide Y.Iwagami H.Izawa K.Yukawa T. Nucleosides Nucleotides 1992, 11: 391 -
4c
Reichman U.Hollenberg DH.Chu CK.Watanabe KA.Fox JJ. J. Org. Chem. 1976, 41: 2042 -
4d
Robins MJ.Wilson JS.Madej D.Low NH.Hansske F.Wnuk SF. J. Org. Chem. 1995, 60: 7902 - 5
Kahne D.Walker S.Cheng Y.Van Engen D. J. Am. Chem. Soc. 1989, 111: 6881 - 6
Gadikota RR.Callam CS.Del Fraino B.Wagner T.Lowary TL. J. Am. Chem. Soc. 2003, 125: 4155 - 7
D’Souza FW.Ayers JD.McCarren PR.Lowary TL. J. Am. Chem. Soc. 2000, 122: 1251 - 11
Nishimura T.Iwai I. Chem. Pharm. Bull. 1964, 12: 352 -
13a
1:
Koole LH.Neidle S.Crawford MD.Krayevski AA.Gurskaya GV.Sandstroem A.Wu JC.Tong W.Chattopadhyaya J. J. Org. Chem. 1991, 56: 6884 -
13b
2:
Robles R.Rodríguez C.Izquierdo I.Plaza MT.Mota A. Tetrahedron: Asymmetry 1997, 8: 2959 -
13c
3 and 4:
Mustafin AG.Gataullin RR.Spirikhin LV.Sultanova VS.Abdrakhmanov IB.Tolstikov GA. Bash. Khim. Zh. 1996, 3: 24 -
13d
20: Ref. 2c.
- 15
Katalenic D.Skaric V. J. Chem. Soc., Perkin Trans. 1 1992, 1065 - 16
Gadikota RR.Callam CS.Lowary TL. Org. Lett. 2001, 3: 607 - 17
Callam CS.Gadikota RR.Lowary TL. J. Org. Chem. 2001, 66: 4549 -
18a
Mizutani K.Kasai R.Nakamura M.Tanaka O.Matsuura H. Carbohydr. Res. 1989, 185: 27 -
18b
Cyr N.Perlin AS. Can. J. Chem. 1979, 7: 2504 -
18c
Serianni AS.Barker R. J. Org. Chem. 1984, 49: 3292 - 19
Bock K.Pedersen C. J. Chem. Soc., Perkin Trans. 2 1974, 293 - See, for example:
-
20a
Amann N.Wagenknecht H.-A. Synlett 2002, 687 -
20b
Whale RF.Coe PL.Walker RT. Nucleosides Nucleotides 1991, 10: 1615 -
20c
Flynn BL.Macolino V.Crisp GT. Nucleosides Nucleotides 1991, 10: 763 -
20d
Hobbs FW. J. Org. Chem. 1989, 54: 3420
References
24: White solid, mp 68-69 °C; Rf 0.61 (hexanes/EtOAc, 5:1); [α]D +129.0 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3, δ) 7.31 (d, 2 H, J = 8.0 Hz), 7.18 (d, 2 H, J = 8.0 Hz), 5.51 (s, 1 H), 4.09 (dd, 1 H, J = 6.2 Hz, 6.2 Hz), 3.97 (d, 1 H, J = 2.8 Hz), 3.77 (d, 1 H, J = 2.8 Hz), 3.55 (dd, 1 H, J = 6.2 Hz, 12.5 Hz), 3.46 (dd, 1 H, J = 6.2 Hz, 12.5 Hz) 2.38 (s, 3 H); 13C NMR (125.7 MHz, CDCl3, δ) 134.4, 129.9, 129.8, 128.3, 86.9, 75.1, 57.7, 55.6, 49.8, 21.0. Anal. Calcd for C12H13N3O2S: C, 54.74; H 4.98. Found: C, 54.70; H, 4.95.
96: White solid, mp 77-78 °C; Rf 0.66 (3:1, hexanes/EtOAc,); [α]D -161.0 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3, δH) 7.31 (d, 2 H, J = 8.0 Hz), 7.18 (d, 2 H, J = 8.0 Hz), 5.58 (s, 1 H), 4.12 (dd, 1 H, J = 6.2 Hz, 6.2 Hz), 3.99 (d, 1 H, J = 2.8 Hz), 3.83 (d, 1 H, J = 2.8 Hz), 3.59 (dd, 1 H, J = 6.2 Hz, 12.5 Hz), 3.49 (dd, 1 H, J = 6.2 Hz, 12.5 Hz) 2.36 (s, 3 H); 13C NMR (125.7 MHz, CDCl3, δC) 134.0, 129.9, 129.8, 128.3, 96.0, 74.3, 57.7, 55.8, 48.9, 21.0. Anal. Calcd for C12H13N3O3S: C, 51.60, 4.69. Found: C, 51.66; H, 4.73.
10General Procedure for Glycosylations. Donor 5 or 6 (0.5 mmol), 2,6-di-tert-butyl-4-methyl pyridine (513 mg, 2.5 mmol), 4 Å molecular sieves (0.1 g) were dried for 3 h under vacuum in the presence of P2O5. To this mixture was added CH2Cl2 (10 mL) and the reaction mixture was cooled to -78 °C. Triflic anhydride (0.17 mL, 0.6 mmol) was added and the mixture was allowed to stir for 10 min before a solution of the persilylated nucleoside (7-11, 0.6 mmol) in CH2Cl2 (1.0 mL) was added dropwise via syringe over 2 min. After 15 min, the reaction mixture turned dark brown/green and a saturated solution of NaHCO3 was added before the solution was allowed to warm to room temperature. The resulting solution was filtered through Celite, dried, filtered, and concentrated to yield a crude oil that was purified by chromatography.
1212: Oil; Rf 0.09 (2:1, hexanes/EtOAc); [α]D +37.2 (c 1.0, CH3OH); 1H NMR (CDCl3, δH) 8.04 (dd, 2 H, J = 1.2 Hz, 8.0 Hz), 7.65-7.61 (m, 2 H), 7.50 (dd, 2 H, J = 8.0 Hz, 8.0 Hz), 6.36 (s, 1 H), 5.72 (d, 1 H, J = 8.2 Hz), 4.73 (dd, 1 H, J = 3.8 Hz, 3.8 Hz), 4.59 (dd, 1 H, J = 3.7 Hz, 12.2 Hz), 4.50 (dd, 1 H, J = 3.9 Hz, 12.2 Hz), 4.12 (d, 1 H, J = 2.8 Hz), 4.01 (d, 1 H, J = 2.8 Hz); 13C NMR (CDCl3, δC) 166.5, 164.4, 151.0, 141.5, 133.9, 129.8, 129.7, 129.2, 128.9, 102.3, 82.5, 77.4, 64.4, 57.0, 56.6; HRMS (ESI) calcd for (M + Na) C16H14N2O6: 353.0750, found 353.0761. 13: Oil; R f 0.15 (2:1, hexanes/EtOAc); [α]D +89.1 (c 1.0, CH3OH); 1H NMR (CDCl3, δH) 8.01 (dd, 2 H, J = 1.2 Hz, 8.1 Hz), 7.50 (dddd, 1 H, J = 1.2 Hz, 1.2 Hz, 7.4 Hz, 7.4 Hz), 7.39 (dd, 2 H, J = 8.0 Hz, 8.0 Hz), 6.23 (s, 1 H), 4.71-4.60 (m, 2 H), 4.35 (dd, 1 H, J = 3.8 Hz, 3.8 Hz), 4.00 (s, 2 H), 1.81 (s, 3 H); 13C NMR (CDCl3, δC) 166.6, 164.0, 151.1, 136.9, 133.8, 130.1, 129.8, 128.9, 111.7, 81.7, 75.5, 62.7, 56.1, 55.9, 12.9; HRMS (ESI) calcd for (M + Na) C17H16N2O6: 367.0906, found 367.0921. 14: Oil; Rf 0.10 (2:1, hexanes/EtOAc); [α]D +73.8 (c 1.0, CH3OH); 1H NMR (CDCl3, δH) 7.92 (dd, 2 H, J = 1.2 Hz, 8.2 Hz), 7.59 (d, 1 H, J = 6.2 Hz), 7.52 (dddd, 1 H, J = 1.2 Hz, 1.2 Hz, 7.4 Hz, 7.4 Hz), 7.39 (dd, 2 H, J = 8.0 Hz, 8.0 Hz), 6.24 (s, 1 H), 4.63 (dd, 1 H, J = 3.8 Hz, 3.8 Hz), 4.49 (dd, 1 H, J = 3.7 Hz, 12.2 Hz), 4.38 (dd, 1 H, J = 3.5 Hz, 12.2 Hz), 4.00 (d, 1 H, J = 2.8 Hz), 3.89 (d, 1 H, J = 2.8 Hz); 13C NMR (CDCl3, δC) 166.6, 157.9 (d, J = 26.3 Hz), 149.7, 140.9 (d, J = 236.4 Hz), 134.1, 129.9, 129.3, 129.0, 125.7 (d, J = 34.9 Hz). 82.7, 64.4, 57.1, 56.7; HRMS (ESI) calcd for (M + Na) C16H13FN2O6: 371.0655, found 371.0667. A small amount of this material was recrystallized from a 10:1 mixture of dichloromethane and hexanes to provide a sample for X-ray crystallography. 15: Oil; Rf 0.29 (2:1, hexanes/EtOAc); [α]D +93.3 (c 1.0, CH3OH); 1H NMR (CDCl3, δH) 8.17 (d, 2 H, J = 1.2 Hz, 8.1 Hz), 8.05 (s, 1 H), 7.59 (dddd, 1 H, J = 1.2 Hz, 1.2 Hz, 7.4 Hz, 7.4 Hz), 7.49 (dd, 2 H, J = 7.9 Hz, 7.9 Hz), 6.17 (s, 1 H), 4.75 (dd, 1 H, J = 5.0 Hz, 12.0 Hz), 4.63 (dd, 1 H, J = 5.0 Hz, 12.0 Hz), 4.41 (dd, 1 H, J = 4.7 Hz, 4.7 Hz), 4.02-4.01 (m, 2 H); 13C NMR (CDCl3, δC) 166.9, 160.9, 150.8, 145.8, 133.8, 130.1, 129.7, 129.0, 82.1, 75.9, 69.3, 62.7, 56.2, 56.0; HRMS (ESI) calcd for (M + Na) C16H13IN2O6: 478.9716, found 478.9722. 17: Oil; R f 0.16 (2:1, hexanes/EtOAc); [α]D +41.3 (c 1.0, CH3OH); 1H NMR (CDCl3, δH) 7.44 (d, 1 H, J = 1.2 Hz), 6.36 (s, 1 H), 4.14 (dd, 1 H, J = 5.9 Hz, 5.9 Hz), 3.95 (d, 1 H, J = 2.8 Hz), 3.86 (d, 1 H, J = 2.8 Hz), 3.60 (d, 2 H, J = 5.9 Hz), 1.90 (d, 3 H, J = 1.2 Hz); 13C NMR (CDCl3, δC) 164.5, 151.2, 136.9, 111.7, 81.6, 76.1, 56.2, 55.5, 50.6, 12.9; HRMS (ESI) calcd for (M + Na) C10H11N5O4: 288.0709, found 288.0720. 18: Oil; Rf 0.11 (2:1, hexanes/EtOAc); [α]D +33.6 (c 1.0, CH3OH); 1H NMR (CDCl3, δH) 7.76 (d, 1 H, J = 6.1 Hz), 6.17 (d, 1 H, J = 1 Hz), 4.21 (dd, 1 H, J = 6.0 Hz, 6.0 Hz), 4.01 (d, 1 H, J = 2.8 Hz), 3.94 (d, 1 H, J = 2.8 Hz), 3.68-3.61 (m, 2 H); 13C NMR (CDCl3, δC) 162.1 (d, J = 26.4 Hz), 149.6, 140.9 (d, J = 236.8 Hz) 125.4 (d, J = 38.5 Hz), 82.9, 76.2, 56.0, 55.7, 50.4; HRMS (ESI) calcd for (M + Na) C9H8FN5O4: 292.0458, found 292.0467. 19; Oil; Rf 0.21 (2:1, hexanes/EtOAc); [α]D +65.4 (c 1.0, CH3OH); 1H NMR (CDCl3, δH) 8.06-8.03 (m, 3 H), 7.95 (d, 2 H, J = 7.4 Hz), 7.62-7.57 (m, 3 H), 7.51-7.45 (m, 4 H), 6.24 (s, 1 H), 4.75 (dd, 1 H, J = 5.4 Hz, 11.9 Hz), 4.61 (dd, 1 H, J = 4.6 Hz, 11.9 Hz), 4.49 (dd, 1 H, J = 4.9 Hz, 5.4 Hz), 4.16 (d, 1 H, J = 2.8 Hz), 4.00 (d, 1 H, J = 2.8 Hz), 13C NMR (CDCl3, δC) 169.0, 166.9, 160.9, 159.0, 133.9, 133.5, 130.0, 129.6, 129.1, 128.9, 128.3, 97.9, 84.2, 76.5, 62.7, 56.9, 56.3; HRMS (ESI) calcd for (M + Na) C23H19N3O6: 456.1172, found 456.1168.
14Wagner, T.; Gadikota, R. R.; Callam, C. S.; Lowary, T. L. Acta Crystallogr., Sect. E., submitted.